Global Cancer Facts & Figures 3rd ed. 2015American Cancer SocietyAtlanta, GA
2.
HoffmanR.M.Clinical practice. Screening for prostate cancerN Engl J Med2011; 365:2013–2019.
3.
QuonJ.S.MoosaviB.KhannaM.FloodT.A.LimC.S.SchiedaN.False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillanceInsights Imaging2015; 6:449–463.
4.
SiddiquiM.M.Rais-BahramiS.TurkbeyB.Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancerJAMA2015; 313:390–397.
5.
AhmedH.U.El-Shater BosailyA.BrownL.C.Diagnostic accuracy of multiparametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory studyLancet2017; 389:815–822.
WeinrebJ.C.BarentszJ.O.ChoykeP.L.PI-RADS Prostate Imaging-Reporting and Data System: 2015, version 2Eur Urol2016; 69:16–40.
8.
AlbertsA.RoobolM.DrostF.J.PSA-density based patient selection for MRI-targeted prostate biopsy could reduce unnecessary biopsy procedures in men on active surveillance for low-grade prostate cancerEur Urol Suppl162017e856
9.
RosenkrantzA.B.BabbJ.S.TanejaS.S.ReamJ.M.Proposed adjustments to PI-RADS version 2 decision rules: impact on prostate cancer detectionRadiology2017; 283:119–129.
10.
RosenkrantzA.B.MengX.ReamJ.M.Likert score 3 prostate lesions: association between whole-lesion ADC metrics and pathologic findings at MRI/ultrasound fusion targeted biopsyJ Magn Reson Imaging2016; 43:325–332.
11.
RosenkrantzA.B.GinocchioL.A.CornfeldD.Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologistsRadiology2016; 280:793–804.
12.
VargasH.A.HötkerA.M.GoldmanD.A.Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of referenceEur Radiol2016; 26:1606–1612.
13.
RosenkrantzA.B.OtoA.TurkbeyB.WestphalenA.C.Prostate Imaging Reporting and Data System (PI-RADS), version 2: a critical lookAJR Am J Roentgenol2016; 206:1179–1183.
14.
WardE.BaadM.PengY.Multi-parametric MR imaging of the anterior fibromuscular stroma and its differentiation from prostate cancerAbdom Radiol (NY)2017; 42:926–934.
15.
HansfordB.G.KarademirI.PengY.Dynamic contrast-enhanced MR imaging features of the normal central zone of the prostateAcad Radiol2014; 21:569–577.
16.
KitzingY.X.PrandoA.VarolC.KarczmarG.S.MacleanF.OtoA.Benign conditions that mimic prostate carcinoma: MR imaging features with histopathologic correlationRadiographics2016; 36:162–175.
17.
RothwaxJ.T.GeorgeA.K.WoodB.J.PintoP.A.Multiparametric MRI in biopsy guidance for prostate cancer: fusion-guidedBiomed Res Int20142014439171
18.
ArsovC.Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsiesEur Urol2015; 68:713–720.
19.
RosenkrantzA.B.VermaS.ChoykeP.Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SARJ Urol2016; 196:1613–1618.
20.
BarrettT.HaiderM.A.The emerging role of MRI in prostate cancer active surveillance and ongoing challengesAJR Am J Roentgenol2017; 208:131–139.
21.
TurkbeyB.BrownA.M.SankineniS.Multiparametric prostate MRI in the evaluation of prostate cancerCA Cancer J Clin2016; 66:326–336.
22.
BjurlinM.A.RosenkrantzA.B.TanejaS.S.MRI-fusion biopsy: the contemporary experienceTransl Androl Urol2017; 6:483–489.
23.
BjurlinM.A.MendhirattaN.WysockJ.S.TanejaS.S.Multiparametric MRI and targeted prostate biopsy: improvements in cancer detection, localization, and risk assessmentCent Eur J Urol2016; 69:9–18.
